Search Results - "Herschler, Gayla"
-
1
Trivalent Live Attenuated Intranasal Influenza Vaccine Administered During the 2003 2004 Influenza Type A (H3N2) Outbreak Provided Immediate, Direct, and Indirect Protection in Children
Published in Pediatrics (Evanston) (01-09-2007)“…Live attenuated influenza vaccine may protect against wild-type influenza illness shortly after vaccine administration by innate immunity. The 2003-2004…”
Get full text
Journal Article -
2
Efficacy of trivalent, cold-adapted, influenza virus vaccine against influenza A (Fujian), a drift variant, during 2003–2004
Published in Vaccine (16-05-2007)“…Abstract In the 2003–2004 influenza season, the predominant circulating influenza A (H3N2) virus in the United States was similar antigenically to…”
Get full text
Journal Article -
3
Estimating Efficacy of Trivalent, Cold-adapted, Influenza Virus Vaccine (CAIV-T) against Influenza A (H1N1) and B Using Surveillance Cultures
Published in American journal of epidemiology (15-08-2003)“…The authors report on a community-based, nonrandomized, open-label study, conducted during the 2000–2001 influenza season in Temple-Belton, Texas, of the…”
Get full text
Journal Article -
4
Every Nose Counts: A New Influenza Vaccine for All Healthy Schoolchildren?
Published in Clinical pediatrics (01-01-2004)“…Influenza is a vaccine-preventable disease. However, influenza virus spreads among children in schools and daycare centers, then to families and communities,…”
Get full text
Journal Article -
5
Herd immunity in adults against influenza-related illnesses with use of the trivalent-live attenuated influenza vaccine (CAIV-T) in children
Published in Vaccine (18-02-2005)“…Highest attack rates for influenza occur in children. Immunization of schoolchildren with inactivated influenza vaccine in Michigan and Japan was associated…”
Get full text
Journal Article -
6
Safety of the Intranasal, Trivalent, Live Attenuated Influenza Vaccine (LAIV) in Children With Intermittent Wheezing in an Open-Label Field Trial
Published in The Pediatric infectious disease journal (01-05-2008)“…BACKGROUND:Safety of the intranasal, trivalent, live attenuated influenza vaccine (LAIV) in children with asthma is unknown. A previous report showed an…”
Get full text
Journal Article -
7
Live Attenuated Influenza Vaccine, Trivalent, Is Safe in Healthy Children 18 Months to 4 Years, 5 to 9 Years, and 10 to 18 Years of Age in a Community-Based, Nonrandomized, Open-Label Trial
Published in Pediatrics (Evanston) (01-09-2005)“…Influenza-associated deaths in healthy children that were reported during the 2003-2004 influenza season heightened the public awareness of the seriousness of…”
Get full text
Journal Article -
8
Direct and total effectiveness of the intranasal, live-attenuated, trivalent cold-adapted influenza virus vaccine against the 2000-2001 influenza A(H1N1) and B epidemic in healthy children
Published in Archives of pediatrics & adolescent medicine (01-01-2004)“…The efficacy of the intranasal, live-attenuated, trivalent cold-adapted influenza virus vaccine (CAIV-T) against influenza A(H3N2) and B infections in healthy…”
Get more information
Journal Article -
9
Live attenuated influenza vaccine, trivalent, is safe in healthy children 18 months to 4 years, 5 to 9 years, and 10 to 18 years of age in a community-based, nonrandomized, open-label trial
Published in Pediatrics (Evanston) (01-09-2005)“…Objective. Influenza-associated deaths in healthy children that were reported during the 2003-2004 influenza season heightened the public awareness of the…”
Get full text
Journal Article